These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968 [TBL] [Abstract][Full Text] [Related]
23. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Dryden C; Young D; Hepburn M; Mactier H BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239 [TBL] [Abstract][Full Text] [Related]
24. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Patrick SW; Davis MM; Lehmann CU; Cooper WO J Perinatol; 2015 Aug; 35(8):650-5. PubMed ID: 25927272 [TBL] [Abstract][Full Text] [Related]
25. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013. Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591 [TBL] [Abstract][Full Text] [Related]
27. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Sarkar S; Donn SM J Perinatol; 2006 Jan; 26(1):15-7. PubMed ID: 16355103 [TBL] [Abstract][Full Text] [Related]
28. The effects of patient volume and level of care at the hospital of birth on neonatal mortality. Phibbs CS; Bronstein JM; Buxton E; Phibbs RH JAMA; 1996 Oct; 276(13):1054-9. PubMed ID: 8847767 [TBL] [Abstract][Full Text] [Related]
29. Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database. Rees P; Carter B; Gale C; Petrou S; Botting B; Sutcliffe AG Arch Dis Child Fetal Neonatal Ed; 2021 Sep; 106(5):494-500. PubMed ID: 33627328 [TBL] [Abstract][Full Text] [Related]
30. Neonatal abstinence syndrome: evaluating the effectiveness of an evidence-based multidisciplinary care approach. Saunders C; King T; Smith S; Buchheit J; Cook K; Edds J; Mefford L; J Perinat Neonatal Nurs; 2014; 28(3):232-40. PubMed ID: 25062525 [TBL] [Abstract][Full Text] [Related]
31. Neonatal abstinence syndrome--postnatal ward versus neonatal unit management. Saiki T; Lee S; Hannam S; Greenough A Eur J Pediatr; 2010 Jan; 169(1):95-8. PubMed ID: 19440732 [TBL] [Abstract][Full Text] [Related]
32. Neonatal abstinence outcomes in post-acute care: A brief report. O'Brien JE; Dumas HM; Leslie D J Pediatr Rehabil Med; 2015; 8(2):157-60. PubMed ID: 26409869 [TBL] [Abstract][Full Text] [Related]
33. Evaluating the effect of hospital setting on outcomes for neonatal abstinence syndrome. Grossman MR; Berkwitt AK; Osborn RR; Citarella BV; Hochreiter D; Bizzarro MJ J Perinatol; 2020 Oct; 40(10):1483-1488. PubMed ID: 32086436 [TBL] [Abstract][Full Text] [Related]
34. Neonatal Abstinence Syndrome and Preterm Infants: A Look at Current Practice. Armbruster D; Schwirian C; Mosier A; Tam WM; Prusakov P Adv Neonatal Care; 2021 Apr; 21(2):107-114. PubMed ID: 33756498 [TBL] [Abstract][Full Text] [Related]
35. Impact of Specialized Nursery Care for Late Preterm Infants on NICU Admission Rate and Length of Stay. Hunt L; Hallford G; Robledo C; Szyld E; Song C Am J Perinatol; 2015 Nov; 32(13):1198-204. PubMed ID: 26070121 [TBL] [Abstract][Full Text] [Related]
36. Impact of late preterm and early term infants on Canadian neonatal intensive care units. Bassil KL; Shah PS; Shah V; Ye XY; Lee SK; Jefferies AL; Am J Perinatol; 2014 Apr; 31(4):269-78. PubMed ID: 23729283 [TBL] [Abstract][Full Text] [Related]
37. A risk-adjusted, composite outcomes score and resource utilization metrics for very low-birth-weight infants. Kaempf JW; Zupancic JA; Wang L; Grunkemeier GL JAMA Pediatr; 2015 May; 169(5):459-65. PubMed ID: 25774741 [TBL] [Abstract][Full Text] [Related]
38. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams. Kaempf JW; Campbell B; Sklar RS; Arduza C; Gallegos R; Zabari M; Brown A; McDonald JV Pediatrics; 2003 Apr; 111(4 Pt 2):e534-41. PubMed ID: 12671173 [TBL] [Abstract][Full Text] [Related]
40. Maternal drug use and its effect on neonates: a population-based study in Washington State. Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]